Journalists from press clubs around the United States selected the finalists, and winners will be announced June 26 in downtown Los Angeles.
The Black Lives Matter activist (at right in photo)—whose political campaign is off to an attention-grabbing start—seeks to tackle the issues of police brutality and criminal justice through education and employment. The Black Lives Matter activist (at right in photo)—whose political campaign is off to an attention-grabbing start—seeks to tackle the issues of police brutality and criminal justice through education and employment.
"How can one be an embodied feminist if, behind closed doors, you're leaving the authentic part of yourself behind in order to please, in order to be a good girl?”
A look back at some of our favorites from the reading stack.
A handful of US personnel made reports on the lethal brutality after it occurred in 2012, and their accounts were brought to public attention by three New York Times writers last week This combined effort has informed the American citizenry, once again, about atrocities committed in its name A handful of U.
The leaks engineered by "the Edward Snowden of banking" have brought to light malpractice that is costing government treasuries hundreds of billions of dollars each year. The IT expert's action has earned him a five-year prison sentence given in absentia.
The leader of the New York City Commission on Human Rights is driven by both a zeal for the public good and personal passion. She is on a mission to give a voice to the voiceless.
Thanks to an anonymous source’s exposure of the inner workings of America’s drone war, we now know that nearly 90 percent of people killed in recent strikes in Afghanistan were not the intended targets.
Pharmaceuticals CEO Martin Shkreli is being called the most hated man in America for raising the price of the HIV drug Daraprim from $13.50 to $750 per pill. Now his earlier pricing decisions are being examined. It is being reported that one such decision led to a 2,000 percent price increase for a medication taken by children suffering from a rare kidney disease.
Although his feet have barely touched the ground, the Labour Party's new leader, a man of principle, is already reinvigorating British politics.